Literature DB >> 8800808

Emerging and reemerging of filoviruses.

H Feldmann1, W Slenczka, H D Klenk.   

Abstract

Filoviruses are causative agents of a hemorrhagic fever in man with mortalities ranging from 22 to 88%. They are enveloped, nonsegmented negative-stranded RNA viruses and are separated into two types, Marburg and Ebola, which can be serologically, biochemically and genetically distinguished. In general, there is little genetic variability among viruses belonging to the Marburg type. The Ebola type, however, is subdivided into at least three distinct subtypes. Marburg virus was first isolated during an outbreak in Europe in 1967. Ebola virus emerged in 1976 as the causative agent of two simultaneous outbreaks in southern Sudan and northern Zaire. The reemergence of Ebola, subtype Zaire, in Kikwit 1995 caused a worldwide sensation, since it struck after a sensibilization on the danger of Ebola virus disease. Person-to-person transmission by intimate contact is the main route of infection, but transmission by droplets and small aerosols among infected individuals is discussed. The natural reservoir for filoviruses remains a mystery. Filoviruses are prime examples for emerging pathogens. Factors that may be involved in emergence are international commerce and travel, limited experience in diagnosis and case management, import of nonhuman primates, and the potential of filoviruses for rapid evolution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800808     DOI: 10.1007/978-3-7091-7482-1_9

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  17 in total

Review 1.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

Review 2.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.

Authors:  Ziying Han; Jonathan J Madara; Yuliang Liu; Wenbo Liu; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Infect Dis       Date:  2015-03-18       Impact factor: 5.226

Review 4.  Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.

Authors:  Ilhem Messaoudi; Gaya K Amarasinghe; Christopher F Basler
Journal:  Nat Rev Microbiol       Date:  2015-10-06       Impact factor: 60.633

5.  Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.

Authors:  M Saijo; M Niikura; S Morikawa; T G Ksiazek; R F Meyer; C J Peters; I Kurane
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.

Authors:  Mangala Rao; Mike Bray; Carl R Alving; Peter Jahrling; Gary R Matyas
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress.

Authors:  Jianhong Lu; Yonggang Qu; Yuliang Liu; Rakesh Jambusaria; Ziying Han; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

8.  Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.

Authors:  Callie E Bounds; Steven A Kwilas; Ana I Kuehne; Jennifer M Brannan; Russell R Bakken; John M Dye; Jay W Hooper; Lesley C Dupuy; Barry Ellefsen; Drew Hannaman; Hua Wu; Jin-an Jiao; Eddie J Sullivan; Connie S Schmaljohn
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

9.  Role for amino acids 212KLR214 of Ebola virus VP40 in assembly and budding.

Authors:  Sarah E McCarthy; Reed F Johnson; Yong-An Zhang; J Oriol Sunyer; Ronald N Harty
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

10.  Role of natural killer cells in innate protection against lethal ebola virus infection.

Authors:  Kelly L Warfield; Jeremy G Perkins; Dana L Swenson; Emily M Deal; Catharine M Bosio; M Javad Aman; Wayne M Yokoyama; Howard A Young; Sina Bavari
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.